China Resources Pharmaceutical (03320.HK) -0.060 (-1.027%) Short selling $32.99M; Ratio 48.000% announced that its subsidiary Tasly Pharmaceutical (600535.SH) +0.470 (+3.322%) released its first-quarter report. Revenue amounted to RMB2.165 billion, representing a YoY increase of 5.3%. Net profit reached RMB365 million, up 9.8% YoY. (de/d)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-24 16:25.) (A Shares quote is delayed for at least 15 mins.)
AASTOCKS Financial News